BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Röpke M, Boltze C, Neumann HW, Roessner A, Schneider-Stock R. Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma. Pathol Res Pract 2003;199:437-44. [PMID: 12924447 DOI: 10.1078/0344-0338-00443] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Karras FS, Schreier J, Körber-Ferl K, Ullmann SR, Franke S, Roessner A, Jechorek D. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma. Pathol Res Pract 2023;244:154414. [PMID: 36963273 DOI: 10.1016/j.prp.2023.154414] [Reference Citation Analysis]
2 Bereza M, Dembiński M, Zając AE, Piątkowski J, Dudzisz-Śledź M, Rutkowski P, Czarnecka AM. Epigenetic Abnormalities in Chondrosarcoma. Int J Mol Sci 2023;24. [PMID: 36901967 DOI: 10.3390/ijms24054539] [Reference Citation Analysis]
3 Agaram NP. Molecular genetics of bone tumors. Diagnostic Histopathology 2022. [DOI: 10.1016/j.mpdhp.2022.09.004] [Reference Citation Analysis]
4 Shimada E, Matsumoto Y, Nakagawa M, Susuki Y, Endo M, Setsu N, Fujiwara T, Iida K, Nabeshima A, Yahiro K, Kimura A, Hirose T, Kanahori M, Oyama R, Oda Y, Nakashima Y. Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma. Br J Cancer 2022;126:1289-300. [PMID: 35017658 DOI: 10.1038/s41416-021-01695-1] [Reference Citation Analysis]
5 Hiemcke-jiwa L, Bovée J. Biology of cartilage tumor family. Bone Cancer 2022. [DOI: 10.1016/b978-0-12-821666-8.00020-7] [Reference Citation Analysis]
6 Pennington Z, Ehresman J, Pittman PD, Ahmed AK, Lubelski D, McCarthy EF, Goodwin CR, Sciubba DM. Chondrosarcoma of the spine: a narrative review. Spine J 2021;21:2078-96. [PMID: 33971325 DOI: 10.1016/j.spinee.2021.04.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hameed M. Malignant Cartilage-Forming Tumors. Surg Pathol Clin 2021;14:605-17. [PMID: 34742483 DOI: 10.1016/j.path.2021.06.005] [Reference Citation Analysis]
8 Malignant Cartilage Tumors. Tumors of the Bones and Joints 2021. [DOI: 10.55418/9781933477138-07] [Reference Citation Analysis]
9 Zając A, Król SK, Rutkowski P, Czarnecka AM. Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype. Cancers (Basel) 2021;13:1317. [PMID: 33804155 DOI: 10.3390/cancers13061317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hart CM, Burke Z, Nobori A, Davis BL. Chondrosarcomas: Conventional and Secondary. Chondrosarcoma 2021. [DOI: 10.1007/978-3-030-74572-1_4] [Reference Citation Analysis]
11 Stöckl S, Lindner G, Li S, Schuster P, Haferkamp S, Wagner F, Prodinger PM, Multhoff G, Boxberg M, Hillmann A, Bauer RJ, Grässel S. SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell Line. Int J Mol Sci 2020;21:E7627. [PMID: 33076370 DOI: 10.3390/ijms21207627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang X, Zhang X, Pan W, Han Y, Li Y, Sun H, Hogendoorn PCW, Cheng H. Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease. Virchows Arch 2021;479:203-7. [PMID: 33047157 DOI: 10.1007/s00428-020-02936-z] [Reference Citation Analysis]
13 Yang T, Bai Y, Chen J, Sun K, Luo Y, Huang W, Zhang H. Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin. J Bone Oncol 2020;22:100293. [PMID: 32742915 DOI: 10.1016/j.jbo.2020.100293] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Scotlandi K, Hattinger CM, Pellegrini E, Gambarotti M, Serra M. Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors. Cells 2020;9:E968. [PMID: 32295254 DOI: 10.3390/cells9040968] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
15 Roessner A, Smolle M, Schoeder V, Haybaeck J. [Cartilage tumors: morphology, genetics, and current aspects of target therapy]. Pathologe 2020;41:143-52. [PMID: 32060685 DOI: 10.1007/s00292-020-00752-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Miao R, Choy E, Raskin KA, Schwab JH, Nielsen GP, Deshpande V, Chebib I, DeLaney TF, Hornicek FJ, Cote GM, Chen YE. Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. Sarcoma 2019;2019:9069272. [PMID: 31915413 DOI: 10.1155/2019/9069272] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
17 Gao L, Hong X, Guo X, Cao D, Gao X, DeLaney TF, Gong X, Chen R, Ni J, Yao Y, Wang R, Chen X, Tian P, Xing B. Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis. Oncotarget 2016;7:43557-69. [PMID: 27248819 DOI: 10.18632/oncotarget.9618] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
18 Gambarotti M, Righi A, Frisoni T, Donati D, Vanel D, Sbaraglia M, Dei Tos A. Dedifferentiated chondrosarcoma with “adamantinoma-like” features: A case report and review of literature. Pathology - Research and Practice 2017;213:698-701. [DOI: 10.1016/j.prp.2017.04.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
19 Zhang H, Gui T, Sang Y, Yang J, Li Y, Liang G, Li T, He Q, Zha Z. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling: JQ1 S UPPRESSES C HONDROSARCOMA C ELL G ROWTH. J Cell Biochem 2017;118:2182-92. [DOI: 10.1002/jcb.25863] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
20 Liu P, Shen JK, Xu J, Trahan CA, Hornicek FJ, Duan Z. Aberrant DNA methylations in chondrosarcoma. Epigenomics 2016;8:1519-25. [PMID: 27686001 DOI: 10.2217/epi-2016-0071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
21 Taminiau AHM, Bovée JVMG, van Rijswijk CSP, Gelderblom HAJ, van de Sande MAJ. Cartilage Tumours of Bone. European Surgical Orthopaedics and Traumatology 2014. [DOI: 10.1007/978-3-642-34746-7_206] [Reference Citation Analysis]
22 Sakamoto A. The molecular pathogenesis of dedifferentiated chondrosarcoma. Indian J Orthop 2014;48:262-5. [PMID: 24932031 DOI: 10.4103/0019-5413.132506] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
23 van Oosterwijk JG, Anninga JK, Gelderblom H, Cleton-jansen A, Bovée JV. Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma. Hematology/Oncology Clinics of North America 2013;27:1021-48. [DOI: 10.1016/j.hoc.2013.07.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
24 van Oosterwijk JG, de Jong D, van Ruler MA, Hogendoorn PC, Dijkstra PD, van Rijswijk CS, Machado I, Llombart-Bosch A, Szuhai K, Bovée JV. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone. BMC Cancer 2012;12:375. [PMID: 22928481 DOI: 10.1186/1471-2407-12-375] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
25 Meijer D, de Jong D, Pansuriya TC, van den Akker BE, Picci P, Szuhai K, Bovée JV. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes Cancer 2012;51:899-909. [PMID: 22674453 DOI: 10.1002/gcc.21974] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 6.5] [Reference Citation Analysis]
26 Franchi A, Baroni G, Sardi I, Giunti L, Capanna R, Campanacci D. Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases. Virchows Arch 2012;460:335-42. [PMID: 22350005 DOI: 10.1007/s00428-012-1206-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Nishida K, Kunisada T, Shen ZN, Kadota Y, Hashizume K, Ozaki T. Chondrosarcoma and peroxisome proliferator-activated receptor. PPAR Res 2008;2008:250568. [PMID: 18725985 DOI: 10.1155/2008/250568] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
28 Fitzgerald MP, Gourronc F, Teoh ML, Provenzano MJ, Case AJ, Martin JA, Domann FE. Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition during Sarcomagenesis. Sarcoma. 2011;2011:598218. [PMID: 21559267 DOI: 10.1155/2011/598218] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
29 Taminiau AHM, Bovée JVMG, van Rijswijk CSP, Gelderblom HAJ, van de Sande MAJ. Cartilage – Forming Bone Tumours. European Instructional Lectures 2011. [DOI: 10.1007/978-3-642-18321-8_3] [Reference Citation Analysis]
30 Chen E, Fletcher CD. Cellular Angiofibroma With Atypia or Sarcomatous Transformation: Clinicopathologic Analysis of 13 Cases. American Journal of Surgical Pathology 2010;34:707-14. [DOI: 10.1097/pas.0b013e3181d74bdb] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
31 Savola S, Böhling T, Knuutila S. Cytogenetic and Molecular Genetic Alterations in Bone Tumors. Bone Cancer 2010. [DOI: 10.1016/b978-0-12-374895-9.00011-6] [Reference Citation Analysis]
32 Staals EL, Palmerini E, Ferrari S, Mercuri M. Non-surgical Treatment of Chondrosarcoma. Bone Cancer 2010. [DOI: 10.1016/b978-0-12-374895-9.00031-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Hamm CA, Xie H, Costa FF, Vanin EF, Seftor EA, Sredni ST, Bischof J, Wang D, Bonaldo MF, Hendrix MJ, Soares MB. Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. PLoS One 2009;4:e8340. [PMID: 20019818 DOI: 10.1371/journal.pone.0008340] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
34 Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314-1321. [PMID: 19718788 DOI: 10.1097/pas.0b013e3181a6cd33] [Cited by in Crossref: 183] [Cited by in F6Publishing: 190] [Article Influence: 13.1] [Reference Citation Analysis]
35 He M, Aisner S, Benevenia J, Patterson F, Harrison LE, Hameed M. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma. Pathology - Research and Practice 2009;205:386-94. [DOI: 10.1016/j.prp.2008.12.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
36 Doganavsargil B, Argin M, Sezak M, Sabah D, Sarsik B, Omur O, Oztop F. Dedifferentiated chondrosarcoma of the thumb: a case report. Arch Orthop Trauma Surg 2009;129:161-6. [PMID: 18066560 DOI: 10.1007/s00402-007-0538-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
37 Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, Bovée JV. The clinical approach towards chondrosarcoma. Oncologist 2008;13:320-9. [PMID: 18378543 DOI: 10.1634/theoncologist.2007-0237] [Cited by in Crossref: 452] [Cited by in F6Publishing: 482] [Article Influence: 30.1] [Reference Citation Analysis]
38 Sopta J, Dordević A, Tulić G, Mijucić V. Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases. J Cancer Res Clin Oncol 2008;134:147-52. [PMID: 17653766 DOI: 10.1007/s00432-007-0262-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
39 Sakamoto A, Yamamoto H, Tanaka K, Matsuda S, Harimaya K, Oda Y, Tsuneyoshi M, Iwamoto Y. Dedifferentiated chondrosarcoma with leukocytosis and elevation of serum G-CSF. A case report. World J Surg Oncol 2006;4:37. [PMID: 16820056 DOI: 10.1186/1477-7819-4-37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Székely E, Török V, Székely T, Riesz P, Romics I. E-Cadherin expression in transitional cell carcinomas. Pathol Oncol Res 2006;12:73-7. [DOI: 10.1007/bf02893447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Papachristou DJ, Goodman MA, Cieply K, Hunt JL, Rao UN. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis. Hum Pathol 2006;37:890-8. [PMID: 16784990 DOI: 10.1016/j.humpath.2006.02.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
42 Bovée JV, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 2005;6:599-607. [PMID: 16054571 DOI: 10.1016/S1470-2045(05)70282-5] [Cited by in Crossref: 149] [Cited by in F6Publishing: 117] [Article Influence: 8.3] [Reference Citation Analysis]
43 Dhillon VS, Shahid M, Husain SA. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. Mol Cancer 2004;3:33. [PMID: 15574200 DOI: 10.1186/1476-4598-3-33] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 3.3] [Reference Citation Analysis]
44 Sandberg AA. Genetics of chondrosarcoma and related tumors. Curr Opin Oncol 2004;16:342-54. [PMID: 15187889 DOI: 10.1097/01.cco.0000129678.72521.e5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
45 Beier F. Cell-cycle control and the cartilage growth plate. J Cell Physiol 2005;202:1-8. [DOI: 10.1002/jcp.20111] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 3.7] [Reference Citation Analysis]